Showing results (141-150 of 232) with videos related to
Sort By:
Pageof 24
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.Pharmacotherapy|January 27, 2004
Temozolomide in patients with advanced cancer: phase I and pharmacokinetic studyMichelle A Rudek, Ross C Donehower, Paul Statkevich, et al.Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.Psychiatric Services (Washington, D.C.)|September 15, 1998
A three-decade perspective on community and public psychiatry training in OregonR Goetz, D L Cutler, D Pollack, et al.Journal of Comparative Effectiveness Research|May 23, 2019
An evidence-based model to consolidate medication adherence cost estimation: the medication adherence cost estimation frameworkRachelle L Cutler, Naomi Van der Linden, Shalom I Charlie Benrimoj, et al.European Journal of Clinical Pharmacology|December 2, 2010
Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjectsTeddy Kosoglou, Yali Zhu, Paul Statkevich, et al.Ciba Foundation Symposium|January 1, 1995
Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humansA J Lewy, R L Sack, M L Blood, et al.Clinical Pharmacology in Drug Development|April 29, 2016
The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of DigoxinTeddy Kosoglou, Yali Zhu, Paul Statkevich, et al.Journal of Clinical Pharmacology|July 14, 2017
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes MellitusV Sahasrabudhe, S G Terra, A Hickman, et al.Clinical Pharmacology in Drug Development|January 19, 2018
A Phase 1, Randomized, Placebo- and Active-Controlled Crossover Study to Determine the Effect of Single-Dose Ertugliflozin on QTc Interval in Healthy VolunteersVaishali Sahasrabudhe, Didier Saur, Kyle Matschke, et al.Pageof 24